Skip to main content

Advertisement

SpringerLink
Log in

Mind and machine in drug design

  • Comment
  • Published:

From Nature Machine Intelligence

View current issue Submit your manuscript

After a difficult start, medicinal chemists are now ready to embrace AI-based methods and concepts in drug discovery, explains Gisbert Schneider.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1: Cartoon representation of the drug design cycle as the interplay of inductive and deductive reasoning.

Jack Burgess.

References

  1. Lee, V. H. Ther. Deliv. 1, 615–619 (2010).

    Article  Google Scholar 

  2. Scannell, J. W., Blanckley, A., Boldon, H. & Warrington, B. Nat. Rev. Drug Discov. 11, 191–200 (2012).

    Article  Google Scholar 

  3. Smietana, K., Siatkowski, M. & Møller, M. Nat. Rev. Drug Discov. 15, 379–380 (2016).

    Article  Google Scholar 

  4. Mignani, S., Huber, S., Tomás, H., Rodrigues, J. & Majoral, J. P. Drug Discov. Today 21, 239–249 (2016).

    Article  Google Scholar 

  5. Jordan, A. M. ACS Med. Chem. Lett. 9, 1150–1152 (2018).

    Article  Google Scholar 

  6. Segler, M. H. S., Preuss, M. & Waller, M. P. Nature 555, 604–610 (2018).

    Article  Google Scholar 

  7. Schütt, K. T., Arbabzadah, F., Chmiela, S., Müller, K. R. & Tkatchenko, A. Nat. Commun. 8, 13890 (2017).

    Article  Google Scholar 

  8. Gupta, A. et al. Mol. Inf. 37, 1700111 (2018).

    Article  Google Scholar 

  9. Merk, D., Grisoni, F., Friedrich, L. & Schneider, G. Commun. Chem. 1, 68 (2018).

    Article  Google Scholar 

  10. Pierce, T. H. & Hohne, B. A. (eds) Artificial Intelligence Applications in Chemistry (American Chemical Society, Washington, 1986).

  11. Gasteiger, J. & Zupan, J. Angew. Chem. Int. Ed. 32, 503–527 (1993).

    Article  Google Scholar 

  12. Walters, W. P., Green, J., Weiss, J. R. & Murcko, M. J. Med. Chem. 54, 6405–6416 (2011).

    Article  Google Scholar 

  13. Sanderson, K. Nat. Rev. Drug Discov. 14, 299–300 (2015).

    Article  Google Scholar 

  14. Schneider, G. Nat. Rev. Drug Discov. 17, 97–113 (2018).

    Article  Google Scholar 

  15. King, R. D. et al. Science 324, 85–89 (2009).

    Article  Google Scholar 

  16. Schneider, P. & Schneider, G. J. Med. Chem. 59, 4077–4086 (2016).

    Article  Google Scholar 

  17. Leeson, P. D. & Springthorpe, B. Nat. Rev. Drug Discov. 6, 881–890 (2007).

    Article  Google Scholar 

  18. Begoli, E., Bhattacharya, T. & Kusnezov, D. Nat. Mach. Intell. 1, 20–23 (2019).

    Article  Google Scholar 

  19. Seifert, V. A. Found. Chem. 19, 209–222 (2017).

    Article  Google Scholar 

  20. Blakemore, D. C. et al. Nat. Chem. 10, 383–394 (2018).

    Article  Google Scholar 

  21. Merk, D., Friedrich, L., Grisoni, F. & Schneider, G. Mol. Inf. 37, 1700153 (2018).

    Article  Google Scholar 

  22. Coley, C. W., Green, W. H. & Jensen, K. F. Acc. Chem. Res. 51, 1281–1289 (2018).

    Article  Google Scholar 

  23. Smith, J. S., Isayev, O. & Roitberg, A. E. Chem. Sci. 8, 3192–3203 (2017).

    Article  Google Scholar 

  24. Schneider, G. Mol. Inf. 37, 1880131 (2018).

    Article  Google Scholar 

  25. Hessler, G. & Baringhaus, K. H. Molecules 23, 2520 (2018).

    Article  Google Scholar 

  26. Mak, K.-K. & Pichika, M. R. Artificial intelligence in drug development: present status and future prospects. Drug Discov. Today. https://doi.org/10.1016/j.drudis.2018.11.014 (2019).

  27. Devillers, J. (ed.) Neural Networks in QSAR and Drug Design (Academic, Cambridge, 1996).

  28. Lohmann, R., Schneider, G. & Wrede, P. Biopolymers 38, 13–29 (1996).

    Article  Google Scholar 

  29. Schneider, G. & Wrede, P. Prog. Biophys. Mol. Biol. 70, 175–222 (1998).

    Article  Google Scholar 

  30. Plowright, A. T. et al. Drug Discov. Today 17, 56–62 (2012).

    Article  Google Scholar 

  31. Graubard, S. R. (ed.). The Artificial Intelligence Debate: False Starts, Real Foundations (MIT Press, Cambridge, 1988).

    Google Scholar 

  32. Topol, E. J. Nat. Med. 25, 44–56 (2019).

    Article  Google Scholar 

  33. Goldberg, K. Nat. Mach. Intell. 1, 2–4 (2019).

    Article  Google Scholar 

Download references

Acknowledgements

I am grateful to the many colleagues, co-workers and students with whom I had the privilege to work on drug design with machine intelligence. This work was financially supported by the Novartis Forschungsstiftung (FreeNovation: AI in Drug Discovery) and the Swiss National Science Foundation (grant no. 205321_182176 to G.S.).

Author information

Authors and Affiliations

  1. Swiss Federal Institute of Technology, Department of Chemistry and Applied Biosciences, RETHINK, Zurich, Switzerland

    Gisbert Schneider

Authors
  1. Gisbert Schneider
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gisbert Schneider.

Ethics declarations

Competing interests

The author declares a potential financial conflict of interest as consultant to the pharmaceutical industry and co-founder of inSili.com GmbH, Zurich.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schneider, G. Mind and machine in drug design. Nat Mach Intell 1, 128–130 (2019). https://doi.org/10.1038/s42256-019-0030-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s42256-019-0030-7

  • Springer Nature Limited

This article is cited by

Search

Navigation